eFFECTOR Therapeutics, Inc.·4

Aug 8, 6:17 PM ET

Warner Douglas J 4

4 · eFFECTOR Therapeutics, Inc. · Filed Aug 8, 2022

Insider Transaction Report

Form 4
Period: 2022-08-08
Warner Douglas J
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-08-08+618,160618,160 total
    Exercise: $0.90Exp: 2032-08-07Common Stock (618,160 underlying)
Footnotes (1)
  • [F1]The stock option vests 25% on August 8, 2023, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION